Cyclacel Pharmaceuticals ... (CYCC)
0.33
-0.04 (-10.54%)
At close: Feb 28, 2025, 3:59 PM
0.31
-5.72%
Pre-market: Mar 03, 2025, 04:10 AM EST
Cyclacel Pharmaceuticals Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 |
| Revenue | 420K | n/a | n/a | n/a | n/a | 150K | n/a | 843K | 1.94M | 1.73M | 1.08M | 69K | 699K | 686K | 911K | 877K | 129K | 387K | 813K | 62K | 170K | n/a | 30K | 98K |
| Cost of Revenue | n/a | 32K | 43K | 20K | 20K | 4.33M | 32K | 9.48M | 12.38M | 18.28M | 11.28M | 6.59M | 360K | 418K | 545K | 429K | 19.57M | 21.2M | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | 420K | -32K | -43K | -20K | -20K | -4.18M | -32K | -8.63M | -10.44M | -16.54M | -10.19M | -6.52M | 339K | 268K | 366K | 448K | -19.44M | -20.82M | 813K | 62K | 170K | n/a | 30K | 98K |
| Operating Income | -25.45M | -27.66M | -22.94M | -10.64M | -9.68M | -9.55M | -9.49M | -14.15M | -16.17M | -22.44M | -17.97M | -15.1M | -16.39M | -16.27M | -18.3M | -42.2M | -32.54M | -33.36M | -29.69M | -26.51M | -17.84M | -19.64M | -19.88M | -13.56M |
| Interest Income | 266K | 210K | 16K | 42K | 224K | 331K | 118K | 37K | 9K | 6K | 13K | 22K | 45K | 37K | 102K | 1.38M | 3.55M | 2.33M | 960K | 421K | 149K | n/a | n/a | n/a |
| Pretax Income | -25.55M | -25.91M | -22.73M | -9.68M | -9.13M | -8.63M | -8.46M | -13.77M | -16.49M | -22.65M | -11.88M | -15.11M | -15.81M | -16.68M | -20.52M | -42.13M | -26.09M | -31.5M | -37.09M | -27.24M | -17.84M | n/a | n/a | -12.94M |
| Net Income | -22.55M | -21.2M | -18.89M | -8.45M | -7.83M | -7.29M | -7.47M | -11.79M | -14.34M | -19.39M | -10.15M | -13.19M | -15.24M | -16.02M | -19.57M | -40.39M | -24.05M | -29.26M | -29.42M | -39.59M | -18.46M | -19.45M | -19.51M | -12.94M |
| Selling & General & Admin | 6.72M | 7.38M | 7.46M | 5.88M | 5.02M | 5.37M | 5.25M | 5.52M | 5.75M | 5.89M | 7.78M | 8.58M | 7.52M | 10.12M | 8.54M | 15.35M | 11.54M | 12.32M | 9.67M | 6.88M | 4.32M | 4.98M | 5.2M | 2.4M |
| Research & Development | 19.16M | 20.27M | 15.48M | 4.76M | 4.66M | 4.33M | 4.24M | 9.48M | 12.38M | 18.28M | 11.28M | 6.59M | 9.21M | 6.41M | 9.77M | 18.87M | 10K | 231K | 13.77M | 19.7M | 13.69M | 14.66M | 14.7M | 11.26M |
| Other Expenses | n/a | 1.3M | 144K | 891K | 231K | 682K | 949K | n/a | 12.13K | n/a | n/a | n/a | 360K | 6.73M | 911K | 8.85M | 21.11M | n/a | 7.06M | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 25.87M | 27.66M | 22.94M | 10.64M | 9.68M | 9.7M | 9.49M | 14.99M | 18.13M | 24.17M | 19.06M | 15.17M | 16.73M | 16.53M | 18.3M | 34.22M | 11.54M | 12.32M | 30.5M | 26.57M | 18.01M | 19.64M | 19.91M | 13.66M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 43K | 177K | 318K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 25.87M | 27.66M | 22.94M | 10.64M | 9.68M | 9.7M | 9.49M | 14.99M | 18.13M | 24.17M | 19.06M | 15.17M | 17.09M | 16.95M | 18.85M | 34.65M | 31.11M | 33.52M | 30.5M | 26.57M | 18.01M | 19.64M | 19.91M | 13.66M |
| Income Tax | -3M | -4.72M | -3.85M | -1.24M | -1.3M | -1.34M | -993K | -1.98M | -2.14M | -3.24M | -1.67M | -1.35M | -565K | -657K | -948K | -1.75M | -2.04M | -2.25M | -274K | 13.08M | 620K | 19.45M | 19.51M | n/a |
| Shares Outstanding (Basic) | 850.82K | 657.62K | 595.08K | 242.22K | 54.41K | 604.71K | 381.56K | 171.25K | 135.65K | 91.48K | 63.16K | 29.94K | 29.94K | 22.53K | 13.21K | 12.16K | 11.83K | 7.97K | 3.96K | 7.4K | 8.79K | 3.96K | 3.96K | 3.96K |
| Shares Outstanding (Diluted) | 850.82K | 657.62K | 595.08K | 242.22K | 54.41K | 604.71K | 381.56K | 171.25K | 135.65K | 91.48K | 63.16K | 29.94K | 29.94K | 22.53K | 13.21K | 12.16K | 11.83K | 7.97K | 3.96K | 7.4K | 8.79K | 4.62K | 4.62K | 4.62K |
| EPS (Basic) | -26.75 | -32.23 | -31.74 | -34.86 | -143.88 | -12.05 | -19.58 | -68.85 | -105.72 | -211.93 | -160.75 | -440.4 | -509.1 | -711.22 | -1.48K | -3.32K | -2.03K | -3.67K | -7.42K | -5.35K | -2.1K | -4.91K | -4.92K | -3.27K |
| EPS (Diluted) | -26.75 | -32.23 | -31.74 | -34.86 | -143.88 | -12.05 | -19.58 | -68.85 | -105.72 | -211.93 | -160.75 | -440.4 | -509.1 | -711.22 | -1.48K | -3.32K | -2.03K | -3.67K | -7.42K | -5.35K | -2.1K | -4.21K | -4.22K | -2.8K |
| EBITDA | -25.42M | -27.62M | -22.69M | -10.62M | -9.66M | -9.52M | -9.46M | -14.02M | -15.96M | -22.26M | -17.9M | -15.05M | -15.57M | -16.18M | -19.67M | -39.95M | -24.75M | -30.13M | -19.45M | -24.48M | -16.91M | -19.64M | -19.88M | -14.18M |
| Depreciation & Amortization | 31K | 32K | 43K | 20K | 20K | 29K | 32K | 133K | 210K | 174K | 70K | 60K | 241K | 457K | 668K | 1.86M | 299K | 1.09M | 1.55M | 1.31M | 929K | n/a | n/a | -621K |